What is TScan Therapeutics, Inc. Common Stock's Market Cap?

TScan Therapeutics, Inc. Common Stock's Market Cap is $23.4M, based on as-reported figures from SEC (XBRL) filings.

What is TScan Therapeutics, Inc. Common Stock's Enterprise Value?

TScan Therapeutics, Inc. Common Stock's Enterprise Value is -$44.0M, based on as-reported figures from SEC (XBRL) filings.

What is TScan Therapeutics, Inc. Common Stock's Price / Sales?

TScan Therapeutics, Inc. Common Stock's Price / Sales is 3.3×, based on as-reported figures from SEC (XBRL) filings.

What is TScan Therapeutics, Inc. Common Stock's EV / Revenue?

TScan Therapeutics, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.

What is TScan Therapeutics, Inc. Common Stock's EV / EBITDA?

TScan Therapeutics, Inc. Common Stock's EV / EBITDA is 0.4×, based on as-reported figures from SEC (XBRL) filings.

What is TScan Therapeutics, Inc. Common Stock's Revenue (TTM)?

TScan Therapeutics, Inc. Common Stock's Revenue (TTM) is $7.1M, based on as-reported figures from SEC (XBRL) filings.

What is TScan Therapeutics, Inc. Common Stock's Net Income (TTM)?

TScan Therapeutics, Inc. Common Stock's Net Income (TTM) is -$117.7M, based on as-reported figures from SEC (XBRL) filings.

What is TScan Therapeutics, Inc. Common Stock's EBITDA?

TScan Therapeutics, Inc. Common Stock's EBITDA is -$117.6M, based on as-reported figures from SEC (XBRL) filings.

What is TScan Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

TScan Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.74, based on as-reported figures from SEC (XBRL) filings.

What is TScan Therapeutics, Inc. Common Stock's EBITDA Margin?

TScan Therapeutics, Inc. Common Stock's EBITDA Margin is -1654.4%, based on as-reported figures from SEC (XBRL) filings.

TScan Therapeutics, Inc. Common Stock (TCRX) Financial Statements

TScan Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00PH1N025

XNAS · usd

0.34▼ 0.05 (-11.93%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close0.39

Day's Range0.33 – 0.38

52-Week Range0.33 – 2.57

Volume1.5M

Avg Volume796.3K

Share Statistics

Shares Outstanding

Employees142

ExchangeXNAS

Listed2021-07-16

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about TScan Therapeutics, Inc. Common Stock (TCRX)

What is TScan Therapeutics, Inc. Common Stock's Market Cap?: TScan Therapeutics, Inc. Common Stock's Market Cap is $23.4M, based on as-reported figures from SEC (XBRL) filings.
What is TScan Therapeutics, Inc. Common Stock's Enterprise Value?: TScan Therapeutics, Inc. Common Stock's Enterprise Value is -$44.0M, based on as-reported figures from SEC (XBRL) filings.
What is TScan Therapeutics, Inc. Common Stock's Price / Sales?: TScan Therapeutics, Inc. Common Stock's Price / Sales is 3.3×, based on as-reported figures from SEC (XBRL) filings.
What is TScan Therapeutics, Inc. Common Stock's EV / Revenue?: TScan Therapeutics, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is TScan Therapeutics, Inc. Common Stock's EV / EBITDA?: TScan Therapeutics, Inc. Common Stock's EV / EBITDA is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is TScan Therapeutics, Inc. Common Stock's Revenue (TTM)?: TScan Therapeutics, Inc. Common Stock's Revenue (TTM) is $7.1M, based on as-reported figures from SEC (XBRL) filings.
What is TScan Therapeutics, Inc. Common Stock's Net Income (TTM)?: TScan Therapeutics, Inc. Common Stock's Net Income (TTM) is -$117.7M, based on as-reported figures from SEC (XBRL) filings.
What is TScan Therapeutics, Inc. Common Stock's EBITDA?: TScan Therapeutics, Inc. Common Stock's EBITDA is -$117.6M, based on as-reported figures from SEC (XBRL) filings.
What is TScan Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: TScan Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.74, based on as-reported figures from SEC (XBRL) filings.
What is TScan Therapeutics, Inc. Common Stock's EBITDA Margin?: TScan Therapeutics, Inc. Common Stock's EBITDA Margin is -1654.4%, based on as-reported figures from SEC (XBRL) filings.